187 related articles for article (PubMed ID: 22816611)
1. Acute myeloid leukemia with 11q23/MLL rearrangement after 'FCR' regimen for chronic lymphocytic leukemia.
Sarid N; Eshel R; Rothman R; Shpringer M; Perry C; Solar I; Dezorella N; Gepstein L; Canaani J; Naparstek E; Polliack A; Herishanu Y
Eur J Haematol; 2012 Nov; 89(5):430-1. PubMed ID: 22816611
[No Abstract] [Full Text] [Related]
2. Translocation (4;11)(p12;q23) with rearrangement of FRYL and MLL in therapy-related acute myeloid leukemia.
Sait SN; Claydon MA; Conroy JM; Nowak NJ; Barcos M; Baer MR
Cancer Genet Cytogenet; 2007 Sep; 177(2):143-6. PubMed ID: 17854671
[TBL] [Abstract][Full Text] [Related]
3. [Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab].
Tsukasaki K
Nihon Rinsho; 2015 Feb; 73 Suppl 2():632-5. PubMed ID: 25831837
[No Abstract] [Full Text] [Related]
4. Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group.
Gröschel S; Schlenk RF; Engelmann J; Rockova V; Teleanu V; Kühn MW; Eiwen K; Erpelinck C; Havermans M; Lübbert M; Germing U; Schmidt-Wolf IG; Beverloo HB; Schuurhuis GJ; Ossenkoppele GJ; Schlegelberger B; Verdonck LF; Vellenga E; Verhoef G; Vandenberghe P; Pabst T; Bargetzi M; Krauter J; Ganser A; Valk PJ; Löwenberg B; Döhner K; Döhner H; Delwel R
J Clin Oncol; 2013 Jan; 31(1):95-103. PubMed ID: 23008312
[TBL] [Abstract][Full Text] [Related]
5. Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.
Balgobind BV; Raimondi SC; Harbott J; Zimmermann M; Alonzo TA; Auvrignon A; Beverloo HB; Chang M; Creutzig U; Dworzak MN; Forestier E; Gibson B; Hasle H; Harrison CJ; Heerema NA; Kaspers GJ; Leszl A; Litvinko N; Nigro LL; Morimoto A; Perot C; Pieters R; Reinhardt D; Rubnitz JE; Smith FO; Stary J; Stasevich I; Strehl S; Taga T; Tomizawa D; Webb D; Zemanova Z; Zwaan CM; van den Heuvel-Eibrink MM
Blood; 2009 Sep; 114(12):2489-96. PubMed ID: 19528532
[TBL] [Abstract][Full Text] [Related]
6. Early cryptococcal meningitis following treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemia.
Marchand T; Revest M; Tattevin P; Chevrier S; Poullot E; Lamy T; Houot R
Leuk Lymphoma; 2013 Mar; 54(3):643-5. PubMed ID: 22924391
[No Abstract] [Full Text] [Related]
7. PDS5A, a novel translocation partner of MLL in acute myeloid leukemia.
Put N; Van Roosbroeck K; Vande Broek I; Michaux L; Vandenberghe P
Leuk Res; 2012 Apr; 36(4):e87-9. PubMed ID: 22230297
[No Abstract] [Full Text] [Related]
8. Therapy-related myeloid neoplasms following fludarabine, cyclophosphamide, and rituximab (FCR) treatment in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Zhou Y; Tang G; Medeiros LJ; McDonnell TJ; Keating MJ; Wierda WG; Wang SA
Mod Pathol; 2012 Feb; 25(2):237-45. PubMed ID: 22080061
[TBL] [Abstract][Full Text] [Related]
9. Progressive multifocal leukoencephalopathy after treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemia.
Herold T; Seiler T; Egensperger R; Trumm C; Bergmann M; Franke D; Mumm FF; Schinwald N; Buske C; Dreyling M
Leuk Lymphoma; 2012 Jan; 53(1):169-72. PubMed ID: 21812535
[No Abstract] [Full Text] [Related]
10. A new chromosomal three-way rearrangement involving MLL masked by a t(9;19)(p11;p13) in an infant with acute myeloid leukemia.
de Jesus Marques-Salles T; Liehr T; Mkrtchyan H; Raimondi SC; Tavares de Souza M; de Figueiredo AF; Rouxinol S; Jordy Macedo FC; Abdelhay E; Santos N; Macedo Silva ML
Cancer Genet Cytogenet; 2009 Feb; 189(1):59-62. PubMed ID: 19167614
[TBL] [Abstract][Full Text] [Related]
11. Therapy-related myelodysplastic syndrome and acute myeloid leukemia in patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide.
Colović M; Suvajdžić N; Janković G; Tomin D; Colović N; Fekete MD; Palibrk V
Biomed Pharmacother; 2011 Aug; 65(5):319-21. PubMed ID: 21775097
[TBL] [Abstract][Full Text] [Related]
12. Masked MLL gene rearrangement was disclosed in the clinical course and sequential development of chromosome abnormality in a patient with therapy related acute myelogenous leukemia.
Hashimoto S; Toba K; Izumi N; Sato N; Takahashi H; Ozawa T; Moriyama M; Aoki S; Furukawa T; Narita M; Takahashi M; Aizawa Y
Leuk Res; 2003 Mar; 27(3):285-90. PubMed ID: 12537982
[TBL] [Abstract][Full Text] [Related]
13. Chemoimmunotherapy with oral low-dose fludarabine, cyclophosphamide and rituximab (old-FCR) as treatment for elderly patients with chronic lymphocytic leukaemia.
Gozzetti A; Candi V; Fabbri A; Schiattone L; Cencini E; Lauria F; Frasconi A; Crupi R; Raspadori D; Papini G; Defina M; Bartalucci G; Bocchia M
Leuk Res; 2014 Aug; 38(8):891-5. PubMed ID: 24934847
[TBL] [Abstract][Full Text] [Related]
14. MLL partner genes in secondary acute lymphoblastic leukemia: report of a new partner PRRC1 and review of the literature.
Douet-Guilbert N; Eveillard JR; Meyer C; Ugo V; Le Bris MJ; Basinko A; Morel F; Marschalek R; De Braekeleer M
Leuk Res; 2014 Nov; 38(11):1316-9. PubMed ID: 25205603
[TBL] [Abstract][Full Text] [Related]
15. Acute myeloid leukemia with associated translocation t(15;17) and 11q23/MLL abnormality.
Campiotti L; Appio L; Casalone R; Righi R; Ageno W; Solbiati F; Grandi AM; Venco A
Leuk Lymphoma; 2008 Mar; 49(3):592-5. PubMed ID: 18297541
[No Abstract] [Full Text] [Related]
16. Therapy-related acute myelogenous leukemia with an 11q23/MLL translocation following adjuvant cisplatin and vinorelbine for non-small-cell lung cancer.
Faller BA; Robu VG; Borghaei H
Clin Lung Cancer; 2009 Nov; 10(6):438-40. PubMed ID: 19900863
[TBL] [Abstract][Full Text] [Related]
17. 11q23 rearrangement and duplication of MLLT1-MLL gene fusion in therapy-related acute myeloid leukemia.
Chin LK; Cheah CY; Michael PM; MacKinnon RN; Campbell LJ
Leuk Lymphoma; 2012 Oct; 53(10):2066-8. PubMed ID: 22335556
[No Abstract] [Full Text] [Related]
18. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia.
Super HG; Strissel PL; Sobulo OM; Burian D; Reshmi SC; Roe B; Zeleznik-Le NJ; Diaz MO; Rowley JD
Genes Chromosomes Cancer; 1997 Oct; 20(2):185-95. PubMed ID: 9331569
[TBL] [Abstract][Full Text] [Related]
19. Excess mortality after treatment with fludarabine and cyclophosphamide in combination with alemtuzumab in previously untreated patients with chronic lymphocytic leukemia in a randomized phase 3 trial.
Lepretre S; Aurran T; Mahé B; Cazin B; Tournilhac O; Maisonneuve H; Casasnovas O; Delmer A; Leblond V; Royer B; Corront B; Chevret S; Delépine R; Vaudaux S; Van Den Neste E; Béné MC; Letestu R; Cymbalista F; Feugier P
Blood; 2012 May; 119(22):5104-10. PubMed ID: 22337714
[TBL] [Abstract][Full Text] [Related]
20. Reduced-dose fludarabine, cyclophosphamide, and rituximab (FCR-Lite) plus lenalidomide, followed by lenalidomide consolidation/maintenance, in previously untreated chronic lymphocytic leukemia.
Mato AR; Foon KA; Feldman T; Schuster SJ; Svoboda J; Chow KF; Valentinetti M; Mrkulic M; Azzollini K; Gadaleta G; Bhattacharyya PK; Zenreich J; Pascual LN; Yannotti K; Kdiry S; Howlett C; Strelec L; Porter D; Bejot C; Goy A
Am J Hematol; 2015 Jun; 90(6):487-92. PubMed ID: 25691474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
